Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Ethical Drug Sales Down 2.0% in August: Crecon
October 10, 2018
- Celgene’s CAR-T Therapy Earns Orphan Status in Japan
October 10, 2018
- Patient Enrollment Completed in Japan PIII Study of Diabetes Treatment Imeglimin: Poxel
October 10, 2018
- 3 Japan Major Pharmas to Launch 2nd Open Drug Reposition Program
October 10, 2018
- Funding Disclosures Reveal Changes in Money Flows; Biz Models, Pricing Reform Driving the Shift
October 9, 2018
- Osaka Univ. Spinout FunPep Raises 460 Million Yen
October 9, 2018
- Canada Approves Mitsubishi Tanabe’s ALS Med Radicava
October 9, 2018
- Belviq Reduces Risk of Progression to Type 2 Diabetes: Eisai
October 9, 2018
- Takeda Alumni Shareholders Send Open Letter Questioning Shire Buyout
October 9, 2018
- Reldesemtiv Shows Efficacy for Spinal Muscular Atrophy in PII: Astellas/Cytokinetics
October 9, 2018
- I/O in Lung Cancer - 7: Oncologist Sees Promise in I/O-I/O Combos, Prods Quest for Cure
October 5, 2018
- Fujifilm Develops New Technology to Search and Design Candidate Compounds Using Structural Formulas Alone
October 5, 2018
- Novo’s Oral GLP-1 Analogue Semaglutide Comparable to Subcutaneous Dulaglutide in No. of AEs: Japan PIIIa Study
October 5, 2018
- Blincyto OK Now in Hand, Amgen Astellas JV Revs Up for Foray into Japan Oncology Market
October 4, 2018
- Amgen to Remain Active Investor in Japan as It Eyes 2020 Launch of Stand-Alone Subsidiary
October 4, 2018
- Daiichi Sankyo/Kite’s CAR-T Cell Therapy Scoops Up Orphan Status for B-Cell Lymphoma
October 4, 2018
- Bavencio on Back Foot, but Merck KGaA Has High Hopes for Next-Gen I/O Therapy M7824
October 3, 2018
- Fujifilm, Taisho Detail Sales Schemes after Tie-Up Dissolution Next March
October 3, 2018
- Kaken Grants Distribution Rights for Efinaconazole to Main Life in Hong Kong, Macau
October 3, 2018
- Adcetris Improves PFS as Frontline Therapy for PTCL in PIII: Takeda/Seattle Genetics
October 3, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…